Bayer Seeks Speedy EMA Review For Diabetic Kidney Disease Drug Finerenone

 
• By Neena Brizmohun
  
Fast speed times clock business working hours moving concept
The EMA has a pathway for fast-tracking its review of new medicines • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Review Pathways

More from Pathways & Standards